Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001857044-24-000001
Filing Date
2024-08-22
Accepted
2024-08-22 10:06:25
Documents
1
Effectiveness Date
2024-08-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 14798
  Complete submission text file 0001857044-24-000001.txt   16079
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

EIN.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-522181 | Film No.: 241230474
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)